A patient with a BMI of 41 began taking an experimental drug…

A patient with a BMI of 41 began taking an experimental drug to reduce weight. The drug was discontinued because of steatorrhea (excess fat in stool) and night-blindness. Inhibition of which of the following best explains the observation of these undesirable side-effects in this patient?